SCN2A and channelopathy: This study could provide insights into the signaling mechanisms underlying neurodevelopmental disorders associated with Nav1.2 channelopathies [38,39,40,41,42,43,44,45], aiding in the development of targeted therapies for these conditions based on modulating Nav1.2 PPIs.